MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer

Metastatic progression of tumors is driven by genetic alterations and tumor‐stroma interaction. To elucidate the mechanism underlying the oncogene‐induced gastric tumor progression, we have developed an organoid‐based model of gastric cancer from GAstric Neoplasia (GAN) mice, which express Wnt1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Juntaro, Hirata, Yuki, Otsuki, Yuji, Suina, Kentaro, Saito, Yoshiyuki, Masuda, Kenta, Okazaki, Shogo, Ishimoto, Takatsugu, Saya, Hideyuki, Nagano, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898706/
https://www.ncbi.nlm.nih.gov/pubmed/34931404
http://dx.doi.org/10.1111/cas.15244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898706/
https://www.ncbi.nlm.nih.gov/pubmed/34931404
http://dx.doi.org/10.1111/cas.15244

Ejemplares similares